Exact Sciences

Inactive

EXAS (NCM)

Exact Sciences Corporation develops cancer screening and diagnostic tests for the U.S. and international markets. Its offerings include Cologuard, a non-invasive stool DNA test for colorectal cancer and pre-cancer, plus Cologuard Plus, Cancerguard, and Genetic Testing. It also provides Oncotype DX tests for breast and colon cancer recurrence risk, OncoDetect and OncoExTra tumor profiling, and RiskGuard hereditary risk testing. It licenses Mayo Clinic, Johns Hopkins, and Freenome. Founded 1995, based in Madison, WI.